Family Office Of America (FOFA) Return on Capital Employed (2022 - 2026)
Family Office Of America (FOFA) posted Return on Capital Employed of 11.01% for Q1 2026, up 86.64% sequentially from 82.44% in Q4 2025, and up 6379.0% YoY from 0.17% in Q1 2025.
Family Office Of America (FOFA) Return on Capital Employed (2022 - 2026) Analysis & Trends
Family Office Of America has reported Return on Capital Employed for 5 years, with the latest figure at 11.01% in Q1 2026.
- Quarterly Return on Capital Employed rose 6379.0% year-over-year to 11.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.01% (up 6379.0% YoY) and the FY2025 annual result came in at 246.5%, down 54332.0% from the prior year.
- Return on Capital Employed grew to 11.01% in Q1 2026 per FOFA's latest filing, from 82.44% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 9444.54% in Q3 2024 and troughed at 1725.4% in Q3 2023.
- A 5-year average of 558.74% and a median of 74.8% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed jumped 1116993 bps in 2024, then sank 948651 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 303.98% in 2022, then soared by 116 bps to 49.71% in 2023, then surged by 1775 bps to 932.12% in 2024, then slumped by 109 bps to 82.44% in 2025, then soared by 87 bps to 11.01% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.01%, 82.44%, and 41.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.86 Bn | 195.26 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.19 Bn | 122.72 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.36 Bn | 109.14 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.32 Bn | 72.78 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.72 Bn | 47.47 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.18 Bn | 22.86 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | -14.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.01% |
| Dec 31, 2025 | -82.44% |
| Sep 30, 2025 | -41.98% |
| Jun 30, 2025 | -46.42% |
| Mar 31, 2025 | -74.80% |
| Dec 31, 2024 | 932.12% |
| Sep 30, 2024 | 9,444.54% |
| Jun 30, 2024 | 3,339.63% |
| Mar 31, 2024 | -990.78% |
| Dec 31, 2023 | 49.71% |
| Sep 30, 2023 | -1,725.40% |
| Jun 30, 2023 | -1,409.50% |
| Mar 31, 2023 | -416.55% |
| Dec 31, 2022 | -303.98% |
| Sep 30, 2022 | -282.11% |